Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer - Concepedia

Concepedia

Publication | Open Access

Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer

DOI Full Paper Access

839

Citations

10

References

2018

Year

Gabriel N. Hortobágyi, Salomon M. Stemmer, H. A. Burris, Yoon Sim Yap, Gabe S. Sonke, Shani Paluch–Shimon, Mario Campone, Katarína Petráková, Kim T. Blackwell, Eric P. Winer,

Annals of Oncology

References

	Year	Citations

Page 1